HK1044290A1 - X射線引導的藥物輸送 - Google Patents

X射線引導的藥物輸送

Info

Publication number
HK1044290A1
HK1044290A1 HK02105951.4A HK02105951A HK1044290A1 HK 1044290 A1 HK1044290 A1 HK 1044290A1 HK 02105951 A HK02105951 A HK 02105951A HK 1044290 A1 HK1044290 A1 HK 1044290A1
Authority
HK
Hong Kong
Prior art keywords
drug delivery
ray guided
guided drug
ray
delivery
Prior art date
Application number
HK02105951.4A
Other languages
English (en)
Inventor
E Hallahan Dennis
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Publication of HK1044290A1 publication Critical patent/HK1044290A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Radiation-Therapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK02105951.4A 1999-04-29 2002-08-14 X射線引導的藥物輸送 HK1044290A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/302,456 US6159443A (en) 1999-04-29 1999-04-29 X-ray guided drug delivery
PCT/US2000/011485 WO2000066182A1 (en) 1999-04-29 2000-04-28 X-ray guided drug delivery

Publications (1)

Publication Number Publication Date
HK1044290A1 true HK1044290A1 (zh) 2002-10-18

Family

ID=23167805

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105951.4A HK1044290A1 (zh) 1999-04-29 2002-08-14 X射線引導的藥物輸送

Country Status (7)

Country Link
US (1) US6159443A (zh)
EP (1) EP1194173A4 (zh)
JP (1) JP2002543164A (zh)
AU (1) AU776899B2 (zh)
CA (1) CA2368748A1 (zh)
HK (1) HK1044290A1 (zh)
WO (1) WO2000066182A1 (zh)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7049140B1 (en) * 1999-04-29 2006-05-23 Vanderbilt University X-ray guided drug delivery
JP2001022865A (ja) * 1999-07-06 2001-01-26 Canon Inc 画像処理装置、画像処理システム、画像処理方法、及び記憶媒体
EP1233752B1 (en) * 1999-11-30 2005-01-26 The Arizona Board of Regents on behalf of The University of Arizona Radiation sensitive liposomes
US7597878B2 (en) * 2000-09-19 2009-10-06 Li-Cor, Inc. Optical fluorescent imaging
AU2002217760A1 (en) * 2000-10-12 2002-04-22 The University Of Tennessee Research Corporation Targeting drug/gene carriers to irradiated tissue
US20100215786A9 (en) * 2000-12-05 2010-08-26 Jensen Claude Jarkae Morinda citrifolia enhanced lip treatment
US6702744B2 (en) 2001-06-20 2004-03-09 Advanced Cardiovascular Systems, Inc. Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery
US7306925B2 (en) * 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
WO2003028640A2 (en) * 2001-10-03 2003-04-10 Vanderbilt University In vivo panning for ligands to radiation-induced molecules
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
US8101157B2 (en) * 2001-10-03 2012-01-24 Vanderbilt University Ligands to radiation-induced molecules
US8608661B1 (en) 2001-11-30 2013-12-17 Advanced Cardiovascular Systems, Inc. Method for intravascular delivery of a treatment agent beyond a blood vessel wall
US7635463B2 (en) * 2002-02-27 2009-12-22 Pharmain Corporation Compositions for delivery of therapeutics and other materials
US7361368B2 (en) 2002-06-28 2008-04-22 Advanced Cardiovascular Systems, Inc. Device and method for combining a treatment agent and a gel
RU2326691C2 (ru) 2002-07-18 2008-06-20 Хеликс Биофарма Корп. Использование уреазы для ингибирования роста раковых клеток
AU2003259846A1 (en) * 2002-08-16 2004-03-03 The General Hospital Corporation Non-invasive functional imaging of peripheral nervous system activation in humans and animals
WO2004069862A1 (ja) * 2003-02-06 2004-08-19 Keio University ペプチド結合体
US7641643B2 (en) 2003-04-15 2010-01-05 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
US8821473B2 (en) 2003-04-15 2014-09-02 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US20070232533A1 (en) 2003-05-09 2007-10-04 Kazuo Umezawa Use of Vinca Alkaloids and Salts Thereof
CN100475271C (zh) * 2003-08-20 2009-04-08 加利福尼亚大学董事会 具有抑制生长激素释放活性的促生长素抑制素类似物
WO2005101466A2 (en) 2003-12-19 2005-10-27 The University Of North Carolina At Chapel Hill Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography
WO2006028993A2 (en) * 2004-09-02 2006-03-16 Vanderbilt University Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides
US7854944B2 (en) 2004-12-17 2010-12-21 Advanced Cardiovascular Systems, Inc. Tissue regeneration
US8303972B2 (en) 2005-04-19 2012-11-06 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US9539410B2 (en) 2005-04-19 2017-01-10 Abbott Cardiovascular Systems Inc. Methods and compositions for treating post-cardial infarction damage
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US20080125745A1 (en) 2005-04-19 2008-05-29 Shubhayu Basu Methods and compositions for treating post-cardial infarction damage
US8187621B2 (en) 2005-04-19 2012-05-29 Advanced Cardiovascular Systems, Inc. Methods and compositions for treating post-myocardial infarction damage
KR20080031383A (ko) 2005-07-05 2008-04-08 베이커 메디컬 리서치 인스티튜트 항응고제 및 그의 용도
JP2007210957A (ja) * 2006-02-10 2007-08-23 Chiba Univ 腫瘍の放射線療法における放射線治療増強剤
US7732190B2 (en) 2006-07-31 2010-06-08 Advanced Cardiovascular Systems, Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US9242005B1 (en) 2006-08-21 2016-01-26 Abbott Cardiovascular Systems Inc. Pro-healing agent formulation compositions, methods and treatments
US9005672B2 (en) 2006-11-17 2015-04-14 Abbott Cardiovascular Systems Inc. Methods of modifying myocardial infarction expansion
US8741326B2 (en) 2006-11-17 2014-06-03 Abbott Cardiovascular Systems Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US8192760B2 (en) 2006-12-04 2012-06-05 Abbott Cardiovascular Systems Inc. Methods and compositions for treating tissue using silk proteins
US8372427B2 (en) 2007-03-05 2013-02-12 Abbott Cardiovascular Systems Inc. Therapeutic composition with enhanced endothelium targeting
WO2009002669A2 (en) * 2007-06-21 2008-12-31 The Johns Hopkins University Small peptides specifically bind to colorectal cancers
WO2009018383A1 (en) * 2007-07-30 2009-02-05 Loma Linda University Medical Center Systems and methods for particle radiation enhanced delivery of therapy
WO2009121055A1 (en) * 2008-03-28 2009-10-01 Georgia Tech Research Corporation Reduced dye probes for the detection of radical oxygen species
US20100209341A1 (en) 2009-02-18 2010-08-19 Csl Limited Treatment of chronic inflammatory conditions
EP2413906B1 (en) 2009-03-31 2017-03-15 The Board of Trustees of the University of Arkansas Method of controlled drug release from a liposome carrier
US8269197B2 (en) 2009-07-22 2012-09-18 Intraop Medical Corporation Method and system for electron beam applications
EA201290846A1 (ru) * 2010-03-01 2013-07-30 Интраоп Медикал Корпорейшн Лучевая терапия, комбинированная с сенсибилизаторами гипоксической клетки
WO2011119114A1 (en) * 2010-03-24 2011-09-29 National University Of Singapore Development of photostable near-ir cyanine dyes for in vivo imaging
CA2798205A1 (en) * 2010-05-03 2011-11-10 University Health Network Imageable activatable agent for radiation therapy and method and system for radiation therapy
US8368453B2 (en) * 2011-05-25 2013-02-05 Analog Devices, Inc. Switch circuits
WO2013019730A1 (en) 2011-07-29 2013-02-07 The Washington University Antibodies to tip-1 and grp78
WO2013070872A1 (en) 2011-11-08 2013-05-16 The Board Of Trustees Of The University Of Arkansas Methods and compositions for x-ray induced release from ph sensitive liposomes
AU2014284100A1 (en) * 2013-06-17 2015-12-24 Viralytics Limited Methods for the treatment of bladder cancer
EP3172222A4 (en) 2014-07-24 2018-03-21 Washington University Compositions targeting radiation-induced molecules and methods of use thereof
DK3180085T3 (da) * 2014-08-13 2020-10-26 Convergent R N R Ltd Midler og metoder til målrettet røntgenterapi
US10111966B2 (en) 2016-06-17 2018-10-30 Magenta Therapeutics, Inc. Methods for the depletion of CD117+ cells
IL268058B2 (en) 2017-01-20 2023-09-01 Magenta Therapeutics Inc Compositions and methods for depleting cd137 plus cells
EP3634459A4 (en) 2017-02-10 2021-01-06 Washington University ANTIBODIES DIRECTED AGAINST TIP1 AND THEIR PROCEDURES FOR USE

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1534956A (en) * 1975-05-15 1978-12-06 Ermans A Method of labeling proteins with technetium
US4515165A (en) * 1980-02-04 1985-05-07 Energy Conversion Devices, Inc. Apparatus and method for detecting tumors
US4670386A (en) * 1980-05-23 1987-06-02 Stephen Sugaar Cancer tests using tumor antigen generated lymphokines and compositions
JPS6058927A (ja) * 1983-09-09 1985-04-05 Nippon Mejifuijitsukusu Kk 放射能標識血小板製剤
US4820505A (en) * 1985-04-04 1989-04-11 Scripps Clinic And Research Foundation Detection of activated platelets with antibodies to thrombospondin
GB8601003D0 (en) * 1986-01-16 1986-02-19 Amersham Int Plc Labelling blood cells
US5328840A (en) * 1989-08-15 1994-07-12 The Research Foundation Of The State University Of New York Method for preparing targeted carrier erythrocytes
US5093104A (en) * 1989-08-17 1992-03-03 Syncor International Corporation Method for labelling leucocytes with indium in-111 oxine
US5382680A (en) * 1990-12-07 1995-01-17 The Center For Innovative Technology Allosteric hemoglobin modifier compounds
US5830856A (en) * 1991-02-08 1998-11-03 Diatide, Inc. Radiolabeled compounds for thrombus imaging
US5334369A (en) * 1991-06-11 1994-08-02 Medical University Of South Carolina Platelet receptor antagonists useful in detecting intravascular platelet aggregation
US5292524A (en) * 1991-09-06 1994-03-08 California Institute Of Technology Blood platelet loaded with diagnostic or therapeutic-containing liposome or reconstituted Sendai virus
AU2773792A (en) * 1991-10-03 1993-05-03 Dana-Farber Cancer Institute, Inc. Leukocyte adhesion molecule-1 (lam-1) and ligand thereof
CA2128866A1 (en) * 1992-01-27 1993-08-05 Raymond P. Goodrich, Jr. Method of inactivation of viral and bacterial blood contaminants
JP3353209B2 (ja) * 1992-04-03 2002-12-03 ジェネンテク，インコーポレイテッド αｖβ３インテグリンに対する抗体
US5565491A (en) * 1994-01-31 1996-10-15 Bristol-Myers Squibb Company Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
US5759542A (en) * 1994-08-05 1998-06-02 New England Deaconess Hospital Corporation Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
US5516881A (en) * 1994-08-10 1996-05-14 Cornell Research Foundation, Inc. Aminoxyl-containing radical spin labeling in polymers and copolymers
WO1996012956A1 (en) * 1994-10-25 1996-05-02 Watson Clinic Foundation Direct fluorescence-conjugated immunoassay for platelet activation
US5962424A (en) * 1995-02-21 1999-10-05 Arch Development Corporation Methods and compositions for targeting selectins

Also Published As

Publication number Publication date
JP2002543164A (ja) 2002-12-17
WO2000066182A1 (en) 2000-11-09
EP1194173A1 (en) 2002-04-10
EP1194173A4 (en) 2003-05-14
AU5123900A (en) 2000-11-17
US6159443A (en) 2000-12-12
CA2368748A1 (en) 2000-11-09
AU776899B2 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
HK1044290A1 (zh) X射線引導的藥物輸送
HK1072177A1 (en) Drug delivery device
HK1079718A1 (en) Intracardiac drug delivery
IL149224A0 (en) Hydrogen-driven drug dosage form
IL137650A0 (en) Drug delivery devices
EP1068874A4 (en) MEDICINE DISPENSING DEVICE IN THE FORM OF AN INHALATOR
NZ513700A (en) Oral drug delivery system
HUP0104901A3 (en) Medicament dispenser
EP1062962A4 (en) INHALATION TYPE DRUG DISPENSER
EP1061987A4 (en) DEVICE FOR ADMINISTERING A MEDICINAL PRODUCT
GB2355252B (en) Improvements in drug delivery devices
GB9924780D0 (en) Medicament dispenser
EG23858A (en) Drug combination
GB9809933D0 (en) Drug delivery device
AU6503399A (en) Drug delivery catheter
GB9930160D0 (en) Drug delivery
GB9904304D0 (en) Drug delivery
GB9917737D0 (en) Multiple therapy drug delivery
GB9900965D0 (en) Inhaled drug delivery
GB9905134D0 (en) Medicament delivery system
GB9917470D0 (en) Medicament delivery system
GB9923273D0 (en) Medicament delivery system
GB9804768D0 (en) Drug delivery
GB9816436D0 (en) Multiple therapy drug delivery
GB9901133D0 (en) Drug delivery system